Advertisement
Home Tags Prescription Drugs

Tag: Prescription Drugs

A case of postoperative acute gouty arthritis following laparoscopic cholecystectomy with umbilical hernioplasty

Post-Op Gouty Arthritis Described in Patient Taking Thiazide

0
Case of postoperative acute gouty arthritis documented, secondary to hydrochlorothiazide use
More than one-third of advanced melanoma patients were still alive five years after starting therapy with nivolumab (Opdivo)

AACR: Nivolumab Appears to Up Survival in Advanced Melanoma

0
One-third of study participants lived five years or more after starting treatment
Network meta-analysis

Network Meta-Analysis Recommends Prostaglandins for Glaucoma

0
Highest-ranking class for reducing intraocular pressure was prostaglandins for 1999, 2004, 2009
For patients with post-myocardial infarction heart failure

Mineralocorticoid Receptor Antagonists No Benefit Post MI

0
MRA in addition to standard therapy does not improve outcome in setting of post-MI heart failure
For renal transplant recipients

Oral Nicotinamide Safe for Renal Transplant Recipients

0
Treatment linked to nonsignificant reductions in new non-melanoma skin cancers
Metformin is associated with reduced cardiovascular mortality compared with sulfonylureas

Lower CVD Mortality for Metformin Versus Sulfonylureas

0
Large analysis found up to 40 percent lower risk of heart disease mortality versus sulfonylureas
Pembrolizumab (Keytruda)

AACR: Pembrolizumab Effective Against Merkel-Cell Carcinoma

0
Intravenous medication blocks programmed death 1 (PD-1) immune inhibitory pathway
A considerable proportion of older patients with atrial fibrillation are not prescribed antithrombotics

Antithrombotic Rx Could Be Optimized for Older A-Fib Patients

0
Use of guideline-recommended stroke risk tools could assist medication review pharmacists
Low-cost generic antiviral drugs are as effective and safe as more expensive brand-name drugs in treating people with hepatitis C

Generic Antivirals Equally Effective to Brand Rx in Hep C

0
Inexpensive antivirals could be a game-changer in many countries, researchers say
Neratinib-paclitaxel is no better than trastuzumab-paclitaxel for progression-free survival in recurrent and/or metastatic ERBB2-positive breast cancer

Neratinib Not Superior to Trastuzumab in ERBB2-Breast CA

0
Neratinib-paclitaxel doesn't improve progression-free survival versus trastuzumab-paclitaxel